• Trial Testing WVE-210201 in DMD Selected for FDA Pilot Program
  • Sarepta and Aldevron Partnering on Gene Therapy Program for DMD and LGMD
  • I’ve Learned How to Deal with Judgment About My Disease
  • DMD Hub Works to Connect Patients with Clinical Trials, Promote Study Sites Across UK
  • PPMD Awards $329K to Researchers Looking to Better Understand Promising Duchenne Therapies
  • Phase 3 Trial of Edasalonexent in DMD Now Enrolling Across US, Global Sites to Follow
  • Capricor Places Hold on Phase 2 Trial of Cell Therapy After Patient Has Allergic Reaction
  • Myonexus’ MYO-102 Earns FDA’s Orphan Drug Status for LGMD 2D
  • Project Hercules Enlists Industry’s Help to Make Duchenne Therapies Affordable
  • Top 10 Muscular Dystrophy Articles of 2018
  • Rising Healthcare Costs Strain EU Budgets Even as New Therapies Flourish
  • PPMD Webinar Takes In-depth Look at MD Cardiac Disease and Recent Research Efforts